Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.99
Equillium, Inc. issued pre-funded warrant to purchase up to 17,698,593 Warrant Shares at $0.0001 exercise price of warrant to RA Capital Healthcare Fund, L.P. for purchase price of $1.8539 per Warrant Share.
- Security
- warrant
- Shares
- pre-funded warrant to purchase up to 17,698,593 Warrant Shares at $0.0001 exercise price
- Purchaser
- RA Capital Healthcare Fund, L.P.
- Consideration
- purchase price of $1.8539 per Warrant Share
Exact text from the filing
a pre-funded warrant to purchase up to 17,698,593 Warrant Shares at a purchase price of $1.8539 per Warrant Share (the “Warrant Price”) to the Investor for gross proceeds to the Company of approximately $35.0 million.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.99
Equillium, Inc. issued 1,179,508 Shares at $1.854 per share of common stock to RA Capital Healthcare Fund, L.P. for gross proceeds of approximately $35.0 million.
- Security
- common stock
- Shares
- 1,179,508 Shares at $1.854 per share
- Purchaser
- RA Capital Healthcare Fund, L.P.
- Consideration
- gross proceeds of approximately $35.0 million
Exact text from the filing
up to 17,698,593 Warrant Shares at a purchase price of $1.8539 per Warrant Share (the “Warrant Price”) to the Investor for gross proceeds to the Company of approximately $35.0 million. The pre-funded warrant will have an exercise price of $0.0001 per Warrant Share, subject to customary adjustments, and will be exercisable at any time after original issuance
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Equillium, Inc. entered into Securities Purchase Agreement with RA Capital Healthcare Fund, L.P. valued at approximately $35.0 million (effective 2026-03-11).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- RA Capital Healthcare Fund, L.P.
- Value
- approximately $35.0 million
- Effective
- 2026-03-11
Exact text from the filing
On March 11, 2026, Equillium, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with RA Capital Healthcare Fund, L.P. (the “Investor”), pursuant to which the Company agreed to sell and issue shares (“Shares”) of the Company’s common stock, par value $0.0001 (“Common Stock”), and a pre-funded warrant to purchase shares of Common Stock (“Warrant Shares”), in a private placement transaction (the “Private Placement”).
View on SEC.gov